Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | CNR1 | P21554 | 2/20 | 0.46 |
| ▸ | CNR2 | P34972 | 2/20 | 0.46 |
| ▸ | FAAH | O00519 | 3/20 | 0.42 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.42 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.42 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.42 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.42 |
| ▸ | PRKCA | P17252 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.42 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7994536 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CNR1CNR2FAAHTRPV1 | |
| SCHEMBL27586618 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CNR1CNR2FAAHTRPV1 | |
| SCHEMBL251323 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CNR1CNR2FAAHTRPV1 | |
| SCHEMBL519182 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CNR1CNR2FAAHTRPV1 | |
| SCHEMBL170304 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CNR1CNR2FAAHTRPV1 | |
| SCHEMBL7072490 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CNR1CNR2FAAHTRPV1 | |
| SCHEMBL251871 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CNR1CNR2FAAHTRPV1 | |
| SCHEMBL438865 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CNR1CNR2FAAHTRPV1 | |
| SCHEMBL251249 | 0.96 | ALDH1A1 (0.42) | ALDH1A1CNR1CNR2FAAHTRPV1 | |
| SCHEMBL250711 | 0.93 | ALDH1A1 (0.39) | ALDH1A1CNR1CNR2FAAHPRKCE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 183 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1214053-A1 | ADJUVANT COMPRISING A POLYOXYETHYLENE ALKYL ETHER OR ESTER AND AT LEAST ONE NONIONIC SURFACTANT | SMITHKLINE BEECHAM BIOLOGICALS s.a. (BE) | 2002-06-19 | — | — | EP | claimed |
| WO-2001021152-A1 | ADJUVANT COMPRISING A POLYXYETHYLENE ALKYL ETHER OR ESTER AND AT LEAST ONE NONIONIC SURFACTANT | SMITHKLINE BEECHAM BIOLOGICALS S.A. (BE) | 2001-03-29 | — | — | WO | claimed |
| US-12042531-B2 | Breast and ovarian cancer vaccines | UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) | 2024-07-23 | — | — | US | disclosed |
| CN-115190911-B | Composition having immunogenicity against SARS coronavirus 2, its preparation method and use | 港大科桥有限公司 | 2024-04-23 | — | — | CN | disclosed |
| CN-116983399-A | Zika vaccine and immunogenic compositions and methods of use thereof | 武田疫苗股份有限公司 | 2023-11-03 | — | — | CN | disclosed |
| CN-116983398-A | Zika vaccine and immunogenic compositions and methods of use thereof | 武田疫苗股份有限公司 | 2023-11-03 | — | — | CN | disclosed |
| CN-116635068-A | Compositions having immunogenicity against influenza and SARS coronavirus 2, methods of making and using the same | 港大科桥有限公司 | 2023-08-22 | — | — | CN | disclosed |
| CN-109248313-B | Compositions for immunization against staphylococcus aureus | 葛兰素史密丝克莱恩生物有限公司 | 2023-01-17 | — | — | CN | disclosed |
| CN-115190911-A | Composition with immunogenicity to SARS coronavirus 2, its preparation method and use | 港大科桥有限公司 | 2022-10-14 | — | — | CN | disclosed |
| CN-115175924-A | PD-1 based vaccines against coronavirus infection | 港大科桥有限公司 | 2022-10-11 | — | — | CN | disclosed |
| CN-114107221-A | Method for producing a virus for the preparation of a vaccine | 武田疫苗股份有限公司 | 2022-03-01 | — | — | CN | disclosed |
| WO-2002067983-A1 | NOVEL VACCINE | GLAXOSMITHKLINE BIOLOGICALS S.A. (BE) | 2002-09-06 | — | — | WO | disclosed |
| EP-1214053-A1 | ADJUVANT COMPRISING A POLYOXYETHYLENE ALKYL ETHER OR ESTER AND AT LEAST ONE NONIONIC SURFACTANT | SMITHKLINE BEECHAM BIOLOGICALS s.a. (BE) | 2002-06-19 | — | — | EP | disclosed |
| EP-1214054-A1 | INTRANASAL INFLUENZA VIRUS VACCINE | SMITHKLINE BEECHAM BIOLOGICALS (S.A.), formerly SMITHKLINE BIOLOGICALS (S.A.) (BE) | 2002-06-19 | — | — | EP | disclosed |
| WO-2002028422-A2 | SPLIT ENVELOPED VIRUS PREPARATION FOR INTRANASAL DELIVERY | GLAXOSMITHKLINE BIOLOGICALS S.A. (BE) | 2002-04-11 | — | — | WO | disclosed |
| WO-2002028426-A1 | SPLIT ENVELOPED VIRUS PREPARATION | GLAXOSMITHKLINE BIOLOGICALS S.A. (BE) | 2002-04-11 | — | — | WO | disclosed |
| WO-2001021152-A1 | ADJUVANT COMPRISING A POLYXYETHYLENE ALKYL ETHER OR ESTER AND AT LEAST ONE NONIONIC SURFACTANT | SMITHKLINE BEECHAM BIOLOGICALS S.A. (BE) | 2001-03-29 | — | — | WO | disclosed |
| WO-2001021151-A1 | INTRANASAL INFLUENZA VIRUS VACCINE | SMITHKLINE BEECHAM BIOLOGICALS S.A. (BE) | 2001-03-29 | — | — | WO | disclosed |
| EP-1069910-A1 | ADJUVANT COMPOSITIONS | GlaxoSmithKline Biologicals S.A. (BE) | 2001-01-24 | — | — | EP | disclosed |
| WO-1999052549-A1 | ADJUVANT COMPOSITIONS | SMITHKLINE BEECHAM BIOLOGICALS S.A. (BE) | 1999-10-21 | — | — | WO | disclosed |